English Adalimumab Tender Marks Progress, But Is Not Perfect

Tender
Five suppliers each were awarded a portion of the English adalimumab market in a novel model for an NHS tender • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products